GPR137B

Across TCGA pan-cancer cohorts, GPR137B mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of GPR137B’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where GPR137B mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types GPR137B is over-expressed in tumor, although a few such as CCRCC and LSCC show the opposite, repressed pattern.

CCRCC, PDAC, and LSCC are the cancer types where GPR137B tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GPR137B mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	All	III,IV	−0.378	.001	5	view →
PDAC	All	All	+0.750	.045	4	view →
LSCC	All	III,IV	−0.407	.027	4	view →
LUAD	All	All	−0.527	.003	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

GPR137B–CCRCC

Open the CCRCC breakdown →